Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation...
34 insider purchases on record · latest filing 2021-06-10.
Insiders have also filed 189 sale transactions at CHRS.